semaglutide compounding news november 2025 Compounded "semaglutide" is not FDA-approved The GLP-1 drug boom has

It should be treated immediately with oral glucose or, if the patient is unconscious or unable to swallow safely, with intravenous glucose or intramuscular or subcutaneous glucagon injection (Figure 13.8)

These medications help with weight loss by controlling appetite and regulating blood sugar

So its a pleasure to have him on the show today to talk about his perspective of GLP-1 receptor agonists, how they can be used in psychiatry

Long-term data

All authors have read and agreed to the published version of the manuscript

While no drug is yet approved specifically for slowing aging, GLP-1s are redefining whats possible by improving multiple age-related conditions